Fact-checked by Grok 2 weeks ago

Tributyrin

Tributyrin, also known as glyceryl tributyrate or butyrin, is a naturally occurring composed of one molecule esterified with three molecules of , with the C₁₅H₂₆O₆ and a molecular weight of 302.36 g/mol. It appears as a clear, colorless to yellow liquid at , with a of -75 °C, a of 305 °C, and a of 1.0335 g/cm³, and it is insoluble in water but soluble in alcohol and ether. Found in products such as , where it contributes to the characteristic , tributyrin serves as a stable for , a short-chain that is released through enzymatic in the . As a , tributyrin offers improved and compared to free , enabling systemic delivery of butyrate, which acts as a histone deacetylase (HDAC) inhibitor with potential , antiproliferative, and gut health-promoting effects. In , it has been investigated in clinical trials for conditions including solid tumors, , , optic neuropathies, and hematopoietic cell transplantation, where it activates caspase-3 to induce in cancer cells and supports mitochondrial function. Beyond therapeutics, tributyrin functions as a agent in foods like baked goods, beverages, and dairy products, approved by regulatory bodies for safe use in limited concentrations. In and , tributyrin supplementation enhances growth performance, feed efficiency, intestinal barrier integrity, antioxidant capacity, and immune responses in and crustaceans, particularly when counteracting the inflammatory effects of plant-based diets. Hydrolyzed by pancreatic lipases, it provides butyrate directly to intestinal cells, modulating and reducing without the volatility or odor associated with free . While generally of low toxicity via ingestion, tributyrin is combustible and incompatible with strong oxidizers, requiring careful handling in industrial applications.

Chemistry

Molecular structure

Tributyrin is a composed of esterified with three molecules of butanoic acid, a short-chain saturated denoted as C4:0. Its chemical formula is C<sub>15</sub>H<sub>26</sub>O<sub>6</sub>, and its systematic IUPAC name is 1,3-bis(butanoyloxy)propan-2-yl butanoate, also known as glyceryl tributyrate or 1,2,3-propanetriyl tributanoate. The molecular structure features a central glycerol backbone, where the three hydroxyl groups of are linked via ester bonds to the carboxyl groups of three butanoic acid molecules (CH<sub>3</sub>CH<sub>2</sub>CH<sub>2</sub>COOH). This results in a triacylglycerol with the general form:
  CH&lt;sub>3&lt;/sub>CH&lt;sub>2&lt;/sub>CH&lt;sub>2&lt;/sub>COO-CH&lt;sub>2&lt;/sub>
                   |
  CH&lt;sub>3&lt;/sub>CH&lt;sub>2&lt;/sub>CH&lt;sub>2&lt;/sub>COO-CH
                   |
  CH&lt;sub>3&lt;/sub>CH&lt;sub>2&lt;/sub>CH&lt;sub>2&lt;/sub>COO-CH&lt;sub>2&lt;/sub>
This symmetric arrangement distinguishes tributyrin as the fully esterified form, unlike monobutyrin (one ester bond) or dibutyrin (two ester bonds), which retain free hydroxyl groups on the moiety and thus exhibit partial esterification. The molecular weight of tributyrin is 302.37 g/.

Physical properties

Tributyrin is a clear, colorless to pale yellow oily liquid at . It exhibits a mild described as cheesy, waxy, creamy, and fatty. The compound has a of -75 °C. Its boiling point is approximately 305 °C at . Tributyrin possesses a of about 1.03 g/cm³ at 20 °C. It is insoluble in (with around 133 mg/L at 37 °C) but readily soluble in solvents including , , and . As a short-chain , tributyrin's oily consistency arises from its structure.

Chemical properties and reactivity

Tributyrin demonstrates relative under neutral conditions and at ambient temperatures, making it suitable for storage and handling without significant decomposition. This stability is attributed to its structure, which resists spontaneous breakdown in the absence of catalysts or extreme shifts. Unlike free , tributyrin is non-volatile with minimal , avoiding issues associated with the volatility of its products. The compound undergoes in acidic or basic environments, cleaving the bonds to yield and . This reaction is typical of triglycerides and can be performed chemically under laboratory conditions, such as acid-catalyzed using solid acid catalysts or base-catalyzed . The general equation for the is: (\ce{CH3CH2CH2COO})3\ce{C3H5} + 3\ce{H2O} \rightarrow 3\ce{CH3CH2CH2COOH} + \ce{C3H8O3} Tributyrin exhibits greater susceptibility to in alkaline media compared to acidic conditions. In terms of reactivity, tributyrin is particularly susceptible to enzymatic by lipases, which preferentially target its short-chain ester linkages. This property underpins its role as a for butyrate, enabling controlled and slow release of the active through gradual rather than immediate liberation.

Occurrence and production

Natural occurrence

Tributyrin occurs naturally as a minor in fats, primarily in where it comprises about 3-4% of the total fat content, representing the main esterified form of in these products. This concentration makes the richest dietary source of tributyrin among common foods. Trace amounts of tributyrin are also present in , cheeses, and fermented products, typically at lower levels than in due to processing and dilution effects. In animals, tributyrin is biosynthesized in the mammary glands through the esterification of , which is generated via microbial of carbohydrates in the of herbivores. Typical tributyrin levels in fat vary between 2-5% of total , influenced by factors such as animal and stage. As a natural precursor to butyrate, tributyrin contributes to the short-chain fatty acid profile in these natural sources.

Industrial synthesis

Tributyrin is primarily produced on an industrial scale through the esterification of glycerol with butyric acid in the presence of acid catalysts, such as sulfuric acid or p-toluenesulfonic acid. This process involves heating the reactants to 100-150°C under reflux conditions, often with azeotropic removal of water using toluene to drive the equilibrium toward ester formation. The reaction proceeds as follows: \mathrm{C_3H_8O_3 + 3 CH_3(CH_2)_2COOH \rightarrow (CH_3(CH_2)_2COO)_3C_3H_5 + 3 H_2O} Typical molar ratios of glycerol to butyric acid range from 1:3 to 1:6, with catalyst concentrations of 1-5 wt%, yielding high-purity tributyrin after neutralization, washing, and distillation. Enzymatic synthesis using immobilized lipases, like Novozyme 435, offers a milder alternative at 40-60°C and ambient pressure, achieving conversions up to 97% with reduced byproduct formation and higher selectivity for pharmaceutical-grade product. These methods are particularly valued for their environmental benefits and ability to produce tributyrin with minimal energy input. Industrial processes routinely achieve tributyrin purity exceeding 97% through , enabling its use in food additives and pharmaceutical formulations. Commercial production has been scaling to meet demands in and nutraceuticals, with key manufacturers employing continuous flow reactors for efficiency.

Biological and pharmacological aspects

Metabolism and bioavailability

Tributyrin exhibits favorable characteristics owing to its lipophilic nature, enabling passive across the epithelial lining of the . Unlike free butyrate, which undergoes rapid uptake and in the proximal gut, tributyrin's esterified structure confers resistance to immediate breakdown, allowing a portion to progress distally while still permitting efficient . This positions tributyrin as an effective for sustained butyrate delivery throughout the . In the gut lumen, tributyrin undergoes hydrolysis primarily by pancreatic and microbial lipases, which cleave its three ester bonds to release butyrate and glycerol in a controlled manner. The process can be summarized by the equation: \text{Tributyrin (glyceryl tributyrate)} \xrightarrow{\text{lipases}} 3 \times \text{butyric acid} + \text{glycerol} This enzymatic cleavage occurs progressively along the intestine, ensuring gradual butyrate liberation rather than a bolus release, which enhances its therapeutic potential compared to direct butyrate administration. Intracellular lipases may further contribute to hydrolysis once absorbed, providing localized butyrate production within enterocytes. The of tributyrin surpasses that of , with improved delivery to the colon due to its stability and slower profile; studies indicate higher colonic butyrate concentrations achievable through this mechanism. Following oral ingestion, butyrate levels typically peak within 1-3 hours, reaching 0-0.45 mM in humans, with a of approximately 40 minutes in animal models. also contribute by further metabolizing residual tributyrin or released butyrate, augmenting the pool of through cross-feeding interactions. A 2025 pharmacokinetic study confirmed tributyrin's short and rapid systemic appearance compared to other butyrate forms, supporting thrice-daily dosing for sustained effects.

Physiological effects

Tributyrin, upon metabolism to butyrate in the , exerts beneficial effects on gut health by promoting production and enhancing integrity. Butyrate stimulates the expression and secretion of MUC2, the primary glycoprotein in the colonic mucus layer, which fortifies the protective barrier against pathogens and supports epithelial . Additionally, it upregulates proteins such as and claudins (e.g., claudin-1), thereby strengthening intestinal barrier function and reducing permeability. These actions contribute to reduced gut inflammation, primarily through butyrate's role as a (HDAC) inhibitor, which modulates inflammatory signaling pathways in intestinal epithelial cells. In terms of epigenetic modulation, butyrate serves as an HDAC inhibitor that influences in colonocytes, the primary cells of the colonic . By inhibiting HDACs, butyrate increases , leading to enhanced transcription of genes involved in cell differentiation, proliferation control, and responses. This epigenetic mechanism helps maintain colonic epithelial integrity and prevents aberrant cellular behaviors associated with . Systemically, increased butyrate availability from tributyrin supplementation improves insulin sensitivity by enhancing and mitochondrial function in peripheral tissues. It also mitigates through gene upregulation and reduced production. Furthermore, butyrate can cross the blood-brain barrier, potentially influencing its permeability and supporting via HDAC inhibition in brain cells. Recent studies as of 2025 suggest tributyrin's potential in , with 8-week oral supplementation showing feasibility and acceptability as an add-on to , possibly via gut-brain axis modulation. Evidence from rodent models demonstrates that tributyrin enhances gut microbiota diversity, as observed in antibiotic-treated mice where supplementation restored alpha-diversity indices like Chao1 and Shannon, alongside shifts toward beneficial bacterial populations. These changes correlate with improved intestinal barrier repair and reduced in models of gut disruption.

Applications and uses

As a dietary supplement

Tributyrin is marketed as a in various over-the-counter formulations, primarily softgels or capsules containing 300 to 600 mg of tributyrin per serving. These products are frequently combined with to support overall gut health. Available under brand names such as "Tri-Butyrin ," these supplements target consumer concerns like leaky gut and (IBS), with manufacturers like Designs for Health incorporating odor-minimizing technologies for better tolerability. They are widely sold through online retailers including and , as well as specialty health sites. For general , recommended intakes typically range from 500 to 1500 mg per day, often delivered via self-emulsifying systems like those in CoreBiome formulations to enhance and in the gut. Tributyrin supplements have gained traction in functional since the , driven by growing interest in postbiotics for digestive support. This compound occurs naturally in , providing a dietary precursor to its supplemental applications.

Therapeutic and research applications

Tributyrin has shown promise in therapeutic applications for gut disorders, particularly in addressing and intestinal barrier repair. In a 2023 preclinical study using antibiotic-treated models, of tributyrin restored composition by increasing beneficial bacteria such as Bifidobacterium and Lactobacillus, while reducing pathogenic species like Proteobacteria. This modulation elevated short-chain fatty acid levels, suppressed inflammatory cytokines including TNF-α and IL-6, and repaired intestinal mucosal damage through enhanced protein expression, suggesting potential for (IBD) interventions where contributes to barrier dysfunction. In , tributyrin exhibits antiproliferative effects primarily through its to butyrate, which inhibits deacetylases (HDACs) and induces in tumor cells. Early studies on human colon cancer cell lines, such as HT-29, demonstrated that tributyrin more effectively suppressed cell growth and promoted compared to free butyrate, with values indicating up to threefold greater potency on a molar basis due to improved cellular uptake and sustained release. These effects were linked to G2/M arrest and increased expression of markers like . Clinically, a completed Phase I trial (NCT00002677) evaluated oral tributyrin in patients with refractory and other solid tumors, establishing its safety profile with dose-limiting toxicities limited to mild gastrointestinal effects, paving the way for further explorations. Emerging evidence supports tributyrin's neurological potential via butyrate's role in crossing the blood-brain barrier to exert neuroprotective effects. A 2024 study in aged mice found that tributyrin supplementation mitigated age-related declines in butyrate-producing , thereby preserving cognitive function and reducing markers in the . Similarly, in models of disruption, tributyrin rescued sheath integrity and behavioral deficits by enhancing (BDNF) expression along the gut-brain axis. A (NCT06501898), terminated due to loss of funding, investigated tributyrin's efficacy for performance enhancement, measuring impacts on metabolite profiles, , and cognitive biomarkers in healthy adults. As of 2025, a pilot is assessing the feasibility and acceptability of 8-week oral tributyrin supplementation in adults with mild-to-severe . Additionally, a Phase 2 trial (NCT07154511) is evaluating tributyrin for improving , thinking, walking, and in people with and cognitive impairments. Tributyrin is also under investigation for , where it attenuates obesity-related and more effectively than butyrate in preclinical models. In high-fat diet-fed mice, tributyrin reduced body , improved glucose , and lowered circulating inflammatory markers via GPR109A receptor , outperforming equimolar butyrate due to enhanced . These findings from 2000s and later studies highlight tributyrin's superior potency in modulating metabolic pathways, such as oxidation, compared to free butyrate.

Safety and regulation

Toxicity profile

Tributyrin demonstrates low acute oral toxicity, with an LD50 value of 3,200 mg/kg body weight in rats, classifying it as relatively safe for ingestion compared to more toxic substances. This profile aligns with its natural occurrence in dietary sources like and cheese, where it is present in small amounts without reported acute adverse effects from normal consumption. In a Phase I clinical trial, side effects such as , , abdominal cramping, , and were observed at high doses up to 400 mg/kg/day. Such side effects are typically mild to moderate and transient, with low doses up to 2,000 mg/day generally well-tolerated and no short-term adverse reactions reported in available studies. Regarding chronic exposure, tributyrin is not classified as carcinogenic, and safety data sheets indicate no adverse effects from prolonged low-level intake in animal models. The (EFSA) has evaluated related short-chain esters as safe for use in at concentrations up to 5 mg/kg complete feed. Butyrate, released from tributyrin, may improve insulin sensitivity in preclinical models, but specific interactions with antidiabetic medications and potential amplification of hypoglycemic effects require further clinical study.

Regulatory status

In the United States, tributyrin is affirmed as (GRAS) by the (FDA) for use as a direct human ingredient, specifically as a agent, under 21 CFR 184.1903. This status is based on its history of safe use in food products and evaluation by the Flavor and Extract Manufacturers Association (FEMA), where it is assigned FEMA number 2223 for purposes. In the , tributyrin is authorized for use as a substance in under (EC) No 1334/2008, often employed to mimic dairy flavors, though it does not carry a specific E-number as it falls under the broader category of flavorings rather than listed additives. As a dietary supplement ingredient, is regulated under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which classifies it as a dietary ingredient permissible for marketing without pre-market approval by the FDA, provided it meets current good manufacturing practices and labeling requirements; no prescription is required for its sale or use. This framework allows tributyrin to be incorporated into supplements targeting gut health, leveraging its low toxicity profile to support such applications. In the pharmaceutical context, tributyrin is classified as an investigational drug with ID DB12709 and has been evaluated in clinical trials, including Phase 1 studies for and unspecified adult solid tumors. As of November 2025, it remains investigational, with ongoing Phase I/II trials for conditions like and solid tumors, but is not approved for routine therapeutic use. Internationally, the (WHO), in collaboration with the (FAO), recognizes tributyrin through the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which has evaluated it as a agent (JECFA number 922) with an not specified due to its low toxicity. Some countries impose restrictions on high-dose claims for butyrate precursors like tributyrin in supplements, requiring substantiation under general regulations to prevent unsubstantiated therapeutic assertions.

References

  1. [1]
    Tributyrin | 60-01-5 - ChemicalBook
    Nov 2, 2025 · Tributyrin (C15H26O6), also known as butyrin or glyceryl tributyrate, is the triester of glycerin and butyric acid. It is prepared by ...Missing: compound | Show results with:compound
  2. [2]
    Oral administration of tributyrin increases concentration of butyrate ...
    Tributyrin is a component of a variety of foodstuffs, particularly dairy products like butter. One gram of tributyrin produces 10 mmol of butyrate. However, ...
  3. [3]
    Tributyrin – Knowledge and References - Taylor & Francis
    Tributyrin is a triglyceride molecule that is naturally found in butter and some butter products. It is a prodrug of butyric acid and can be used as a ...
  4. [4]
    Tributyrin - an overview | ScienceDirect Topics
    Tributyrin is a prodrug of butyric acid with favorable pharmacokinetic and efficacy profiles, which has entered clinical studies for solid tumors.
  5. [5]
    Tributyrin: Uses, Interactions, Mechanism of Action | DrugBank Online
    This compound belongs to the class of organic compounds known as triacylglycerols. These are glycerides consisting of three fatty acid chains covalently bonded ...Missing: scientific | Show results with:scientific
  6. [6]
  7. [7]
    Tributyrin supplementation in fish and crustacean nutrition: A review
    Nov 3, 2022 · Tributyrin (TB), a triglyceride composed of butyric acid and glycerol, is one of these butyric acid derivates, which has been widely studied and ...
  8. [8]
    Tributyrin | C15H26O6 | CID 6050 - PubChem - NIH
    Tributyrin | C15H26O6 | CID 6050 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, ...Missing: scientific sources
  9. [9]
  10. [10]
    Tributyrin, 97% 100 mL | Buy Online | Thermo Scientific Chemicals
    IUPAC Name, 2,3-di(butanoyloxy)propyl butanoate. SMILES, CCCC(=O)OCC(COC(=O)CCC) ... Chemical Name or Material, Tributyrin, 98%. Show More Show Less. Product ...
  11. [11]
    Tributyrin 60-01-5 | TCI AMERICA - TCI Chemicals
    Flash point, 180 °C ; Specific Gravity (20/20), 1.04 ; Refractive Index, 1.44 ; Solubility in water, Insoluble ; Degree of solubility in water, 133 mg/l 37 °C.Missing: density | Show results with:density
  12. [12]
    None
    ### Summary of Section 10: Stability and Reactivity for Tributyrin
  13. [13]
    Hydrolysis of Triglycerides Using Solid Acid Catalysts
    In this study, the feasibility of a continuous reaction system using a solid acid for the hydrolysis of TGs at atmospheric pressure has been investigated. This ...
  14. [14]
    A broad pH range indicator-based spectrophotometric assay for true ...
    Methods. A broad pH range indicator-based spectrophotometric assay for true lipases using tributyrin and tricaprylin.
  15. [15]
    Biosensors and Bioassays Based on Lipases, Principles and ... - NIH
    Feb 10, 2019 · Tributyrin can be designated as a common substrate for lipases of various origin. In a study, tributyrin hydrolysis to dibutyrin and butyrate ...
  16. [16]
    Butyrate, Neuroepigenetics and the Gut Microbiome: Can a High ...
    ... milk of ruminant animals, such as cows. Butter contains 3–4% butyric acid, in the form of tributyrin (butyryl triglyceride), making it the richest dietary ...
  17. [17]
    Protective role of butyrate in obesity and diabetes: New insights
    Although butter is the most abundant source of dietary butyrate (up to 3 g per 100 g), the best way to increase the amount of intestinal butyrate is by ...
  18. [18]
    Incorporation of Carbon from Acetate and Butyrate into Milk ...
    The incorporation of carbon from acetate into milk fat clearly confirmed the lipogenic nature of this substrate, especially the contribution of acetate to the ...
  19. [19]
    CN107652180A - The production method of tributyrin - Google Patents
    The present invention provides a kind of production method of tributyrin, including:Using butyric acid and glycerine as raw material, high content tributyrin ...
  20. [20]
    Butyric acid and prospects for creation of new medicines based on ...
    Mar 4, 2024 · Tributyrin production is based on the azeotropic esterification of glycerin and butanoic acid, where toluene acts as an azeotropic agent and ...
  21. [21]
    Esterified Butyrate Feed Additives - Animal Health - Proviron
    Esterification is our core business. Monoglycerides and tributyrin are made by esterification. In our esterification process, a glycerol and free fatty acids ...<|control11|><|separator|>
  22. [22]
    (PDF) Esterification route to produce glyceryl tributyrate
    studied to react glycerol and butyric acid to prepare an important ester, glyceryl tributyrate, also known as tributyrin. The results of experimental ...
  23. [23]
    Tributyrin - Silo Spa
    SILO started the production of tributyrin in 2004. The Tributyrin produced by SILO is characterized by a high level of purity and a high amount of ...
  24. [24]
    Lactobacillus GG and Tributyrin Supplementation Reduce Antibiotic ...
    Tributyrin is neutral, chemically stable, and rapidly hydrolyzed by pancreatic and gastric lipases to glycerol and 3 butyrate molecules. There are several ...Lactobacillus Gg And... · Materials And Methods · DiscussionMissing: bioavailability | Show results with:bioavailability
  25. [25]
  26. [26]
    The short chain fatty acid, butyrate, stimulates MUC2 mucin ...
    May 11, 2007 · Butyrate stimulates MUC2 mucin production in LS174T cells, inhibits proliferation, and causes cell-cycle arrest, while also inhibiting HDACs.
  27. [27]
    Butyrate promotes the recovering of intestinal wound healing ...
    Butyrate promotes the recovering of intestinal wound healing through its positive effect on the tight junctions · Authors · Affiliation.Missing: tributyrin mucin production
  28. [28]
    Butyrate: A Double-Edged Sword for Health? - PMC - PubMed Central
    Feb 9, 2018 · With anti-inflammatory properties, butyrate enhances intestinal barrier function and mucosal immunity. However, the role of butyrate in obesity ...
  29. [29]
    Butyrate Regulates Its Own Metabolic Fate as an HDAC inhibitor in ...
    Oct 3, 2018 · Butyrate is the primary energy source for colonic epithelial cells (colonocytes). Butyrate also regulates gene expression by inhibiting histone ...
  30. [30]
    The Warburg Effect Dictates the Mechanism of Butyrate-Mediated ...
    Nov 30, 2012 · The Warburg effect mediates butyrate's action on cell proliferation. Butyrate regulates histone acetylation and gene expression as an acetyl-CoA donor.
  31. [31]
    Butyrate Improves Insulin Sensitivity and Increases Energy ... - PMC
    On the high-fat diet, supplementation of butyrate prevented development of insulin resistance and obesity in C57BL/6 mice.
  32. [32]
    Butyrate to combat obesity and obesity‐associated metabolic ...
    Jul 20, 2022 · Besides the weight loss-associated beneficial effects on glucose homeostasis, butyrate supplementation also attenuated oxidative stress and ...
  33. [33]
    Tributyrin alleviates gut microbiota dysbiosis to repair intestinal ...
    Jul 31, 2023 · On the other hand, tributyrin (TB) is a pre-butyrate drug without an unpleasant odor compared to direct butyrate intervention. Additionally ...Missing: appearance | Show results with:appearance<|control11|><|separator|>
  34. [34]
    Tributyrin alleviates gut microbiota dysbiosis to repair intestinal ...
    Jul 31, 2023 · TB improved the diversity and altered the structure of gut microbiota in antibiotic-induced mice. Among the α diversity indexes, Chao1 and ...Missing: rodent | Show results with:rodent
  35. [35]
    Designs for Health Tri-Butyrin Supreme - 3-in-1 Butyric Acid ...
    3-in-1 Butyric Acid (Butyrate) Postbiotics for Gut Health & Gut Permeability Support - Tributyrin Supplement with Odor-Minimizing Innovation (60 Softgels)
  36. [36]
    Tributyrin Supplements - Walmart
    Tributyrin Supplements(19) ; Deva Vegan Tributyrin, 500 mg , 90 Vegan Caps. Deva Vegan Tributyrin, 500 mg , 90 Vegan Caps. $2290 ; Tributyrin 500mg 120 Vegetarian ...
  37. [37]
    Amazon.com: Tributyrin Supplement for Gut & Immune 800mg
    800mg | High Bioavailability with Microencapsulated Probiotics & Prebiotics - Advanced Liquid-Filled Tributyrin Complex, Gluten Free, 180 Capsules
  38. [38]
  39. [39]
    What is Tributyrin and Where Can I Buy Tributyrin Supplements?
    Tributyrin is a triglyceride, a natural butyrate, and a short-chain fatty acid, found in supplements like CoreBiome, and is a superior form for digestion.
  40. [40]
    Amazon.com: Tributyrin Supplement - Gut Health & Digestive Support
    NEXT GENERATION POSTBIOTIC: Tributyrin is a special form of butyrate with a superior delivery of butyrate to help restore your gut lining, reduce occasional ...
  41. [41]
    Tributyrin: Benefits and Drawbacks of Supplemental Butyrate in IBS ...
    Feb 14, 2023 · ... doses, which she describes as 600-1200 mg/day of tributyrin. ... Designs for Health Dietary Supplement Specialist Certificate. About ...
  42. [42]
    Tributyrin: The Gut Health Optimizer - The PricePlow Blog
    Dec 15, 2020 · Tributyrin is the most effective way to supplement butyrate / butyric acid, with incredible benefits for gut health and the gut microbiome.Tributyrin Is A Precursor Of... · Intra-Intestinal Effects Of... · Benefits Of Tributyrin<|control11|><|separator|>
  43. [43]
    Tributyrin, a stable and rapidly absorbed prodrug of butyric acid ...
    Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells.Missing: hydrolysis pH<|separator|>
  44. [44]
    Age-associated temporal decline in butyrate-producing bacteria ...
    Aug 25, 2024 · TB attenuates the age-associated decrease in gut microbiome diversity and dysbiosis in 3×Tg mice. Cecal contents of 3×Tg mice given oral TB ...
  45. [45]
    Microbiota–gut–brain axis and its therapeutic applications ... - Nature
    Feb 16, 2024 · Moreover, the administration of tributyrin, a prodrug of butyrate, rescued the myelin dysregulation and behavioral deficits in antibiotic- ...
  46. [46]
    Tributyrin: Time Course & Efficacy to Improve Health & Performance
    Details for study NCT06501898, | ClinicalTrials ... Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
  47. [47]
    Tributyrin Attenuates Metabolic and Inflammatory Changes ...
    Sep 1, 2020 · Tributyrin attenuates metabolic and inflammatory changes associated with obesity through a GPR109A-dependent mechanism.
  48. [48]
    Tributyrin attenuates obesity-associated inflammation and insulin ...
    Jul 15, 2012 · The aim of this study was to investigate whether treatment with tributyrin (Tb; a butyrate prodrug) results in protection against diet-induced ...
  49. [49]
    glyceryl tributyrate, 60-01-5 - The Good Scents Company
    Sec. 184.1903 Tributyrin. Physical Properties: Appearance: colorless clear oily liquid (est).
  50. [50]
    Phase I study of the orally administered butyrate prodrug, tributyrin ...
    Grades 1 and 2 toxicities included diarrhea, headache, abdominal cramping, nausea, anemia, constipation, azotemia, lightheadedness, fatigue, rash, alopecia, ...Missing: NCT06501898 | Show results with:NCT06501898
  51. [51]
    [PDF] Safety Data Sheet: Tributyrin - Chemos GmbH&Co.KG
    Sep 28, 2023 · SECTION 9: Physical and chemical properties. 9.1. Information on basic physical and chemical properties. Physical state liquid. Colour.
  52. [52]
    Chemical group 1 (CG 1) for all animal species - EFSA
    Apr 5, 2013 · The remaining substances are considered safe for all animal species at 5 mg/kg complete feed (with a margin of safety between 1 and 120) and at ...
  53. [53]
    Protective role of butyrate in obesity and diabetes: New insights - PMC
    Nov 24, 2022 · In addition, it plays a key role in reducing glycemia and improving body weight control and insulin sensitivity. The major mechanisms involved ...
  54. [54]
    21 CFR 184.1903 -- Tributyrin. - eCFR
    The affirmation of this ingredient as generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good ...
  55. [55]
    (TRI-)BUTYRIN | FEMA - Flavor and Extract Manufacturers Association
    GRAS Reference 2223 ... Updated use levels and food categories collected as part of the FDA's SLR project are available from the FEMA office for this flavor ...
  56. [56]
    Dietary Supplement Health and Education Act of 1994
    The Dietary Supplement Health and Education Act of 1994 establishes standards for dietary supplements, including safety, claims, and labeling, and defines  ...
  57. [57]
    Dietary Supplements - FDA
    Oct 1, 2024 · FDA regulates dietary supplements under a different set of regulations than those covering conventional foods and drug products.
  58. [58]
    tributyrin - WHO | JECFA
    TRIBUTYRIN ; JECFA number. 922 ; COE number. 747 ; FEMA number. 2223 ; Functional Class. Flavouring Agent FLAVOURING_AGENT ; Tox Monograph: FAS 48-JECFA 57/333.
  59. [59]
    Questions and Answers on Dietary Supplements - FDA
    Feb 21, 2024 · Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed. Generally, a firm does not have to provide ...Missing: tributyrin | Show results with:tributyrin